Ci Medical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: JP3346190006
JPY
1,492.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
23,476.00
22,657.00
22,245.00
20,932.00
12,370.00
11,946.00
11,980.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
23,476.00
22,657.00
22,245.00
20,932.00
12,370.00
11,946.00
11,980.00
Raw Material Cost
15,126.00
14,981.00
14,360.00
13,748.00
9,183.00
8,914.00
8,980.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.00
37.00
23.00
19.00
13.00
6.00
7.00
Selling and Distribution Expenses
6,932.00
6,967.00
6,499.00
7,059.00
2,606.00
2,620.00
2,551.00
Other Expenses
-1.30
-3.70
-2.30
-1.90
-0.80
-0.20
0.00
Total Expenditure (Excl Depreciation)
22,058.00
21,948.00
20,859.00
20,807.00
11,794.00
11,538.00
11,538.00
Operating Profit (PBDIT) excl Other Income
1418
709
1386
125
576
408
442
Other Income
384.00
128.00
-24.00
210.00
-27.00
-9.00
108.00
Operating Profit (PBDIT)
2,106.00
1,193.00
2,047.00
887.00
1,098.00
949.00
1,114.00
Interest
13.00
37.00
23.00
19.00
13.00
6.00
7.00
Exceptional Items
-48.00
1,362.00
-226.00
4,729.00
-6.00
0.00
-51.00
Gross Profit (PBDT)
8,350.00
7,676.00
7,885.00
7,184.00
3,187.00
3,032.00
3,000.00
Depreciation
304.00
356.00
685.00
552.00
549.00
550.00
564.00
Profit Before Tax
1,740.00
2,162.00
1,109.00
5,048.00
528.00
393.00
492.00
Tax
502.00
707.00
167.00
278.00
189.00
143.00
142.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,100.00
1,367.00
930.00
4,759.00
330.00
248.00
343.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,100.00
1,367.00
930.00
4,759.00
330.00
248.00
343.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
138.00
88.00
13.00
11.00
8.00
2.00
7.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,238.00
1,455.00
943.00
4,770.00
338.00
250.00
350.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
27,890.00
26,817.00
26,095.00
25,061.00
20,423.00
20,062.00
20,059.00
Earnings per share (EPS)
22.0
27.34
18.58
95.2
6.6
4.94
6.86
Diluted Earnings per share
22.0
27.34
18.58
95.2
6.6
4.94
6.86
Operating Profit Margin (Excl OI)
6.04%
3.13%
6.23%
0.6%
4.66%
3.42%
3.69%
Gross Profit Margin
8.71%
11.11%
8.06%
26.75%
8.71%
7.89%
8.81%
PAT Margin
4.69%
6.03%
4.18%
22.74%
2.67%
2.08%
2.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 89.78% vs 10.47% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 266.27% vs -52.53% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 53.07% vs 1.99% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Ci Medical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
23,476.00
1,48,179.00
-1,24,703.00
-84.16%
Other Operating Income
0.00
0.00
0.00
Total Operating income
23,476.00
1,48,179.00
-1,24,703.00
-84.16%
Raw Material Cost
15,126.00
1,36,426.00
-1,21,300.00
-88.91%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.00
17.00
-4.00
-23.53%
Selling and Distribution Expenses
6,932.00
10,946.00
-4,014.00
-36.67%
Other Expenses
-1.30
-1.70
0.40
23.53%
Total Expenditure (Excl Depreciation)
22,058.00
1,47,372.00
-1,25,314.00
-85.03%
Operating Profit (PBDIT) excl Other Income
1,418.00
807.00
611.00
75.71%
Other Income
384.00
513.00
-129.00
-25.15%
Operating Profit (PBDIT)
2,106.00
2,261.00
-155.00
-6.86%
Interest
13.00
17.00
-4.00
-23.53%
Exceptional Items
-48.00
0.00
-48.00
Gross Profit (PBDT)
8,350.00
11,753.00
-3,403.00
-28.95%
Depreciation
304.00
941.00
-637.00
-67.69%
Profit Before Tax
1,740.00
1,304.00
436.00
33.44%
Tax
502.00
587.00
-85.00
-14.48%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,100.00
693.00
407.00
58.73%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,100.00
693.00
407.00
58.73%
Share in Profit of Associates
0
0
0.00
Minority Interest
138.00
23.00
115.00
500.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,238.00
716.00
522.00
72.91%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
27,890.00
1,04,287.00
-76,397.00
-73.26%
Earnings per share (EPS)
22.00
14.36
7.64
53.20%
Diluted Earnings per share
22.00
14.36
7.64
53.20%
Operating Profit Margin (Excl OI)
6.04%
0.54%
0.00
5.50%
Gross Profit Margin
8.71%
1.52%
0.00
7.19%
PAT Margin
4.69%
0.47%
0.00
4.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,347.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 3.61% vs 1.85% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 89.78% vs 10.47% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 123.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -14.91% vs 54.29% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 266.27% vs -52.53% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 172.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 61.69% vs -48.58% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 53.07% vs 1.99% in Jun 2024

Quarterly - Interest
Interest 1.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -64.86% vs 60.87% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.04%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024